FDA Re-evaluation of Therapeutic Peptides BPC-157 KPV and Semax and the Future of Compounding Regulations
The United States Food and Drug Administration (FDA) has formally signaled a significant shift in its regulatory oversight of several…
MHRA Launches Investigation Into UK Health Clinics Over Promotion of Unregulated Experimental Peptides
The Medicines and Healthcare products Regulatory Agency (MHRA) has formally initiated an investigation into several United Kingdom-based health and wellness…
MHRA Launches Comprehensive Investigation Into UK Clinics Promoting Unregulated Experimental Peptides and Unauthorized Medicinal Claims
The Medicines and Healthcare products Regulatory Agency (MHRA) has formally initiated an investigation into several private health clinics across the…
